Ligand Pharmaceuticals
LGND
LGND
259 hedge funds and large institutions have $2.5B invested in Ligand Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 109 increasing their positions, 91 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
259
Holders Change
-6
Holders Change %
-2.26%
% of All Funds
6.92%
Holding in Top 10
7
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-50%
% of All Funds
0.19%
New
27
Increased
109
Reduced
91
Closed
32
Calls
$12.4M
Puts
$14M
Net Calls
-$1.62M
Net Calls Change
+$4.32M
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$95.9M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$22.5M |
| 3 |
Goldman Sachs
New York
|
+$19.3M |
| 4 |
O
OppenheimerFunds
New York
|
+$18.7M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$15.3M |
Top Sellers
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$55.2M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$30M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$29.6M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
-$27.8M |
| 5 |
DMK
David M. Knott
|
-$20.6M |
